| First Author | Ntokou A | Year | 2017 |
| Journal | Genesis | Volume | 55 |
| Issue | 12 | PubMed ID | 29045046 |
| Mgi Jnum | J:250476 | Mgi Id | MGI:6102973 |
| Doi | 10.1002/dvg.23080 | Citation | Ntokou A, et al. (2017) A novel mouse Cre-driver line targeting Perilipin 2-expressing cells in the neonatal lung. Genesis 55(12) |
| abstractText | Pulmonary diseases such as chronic obstructive pulmonary disease, lung fibrosis, and bronchopulmonary dysplasia are characterized by the destruction or malformation of the alveolar regions of the lung. The underlying pathomechanisms at play are an area of intense interest since these mechanisms may reveal pathways suitable for interventions to drive reparative processes. Lipid-laden fibroblasts (lipofibroblasts) express the Perilipin 2 (Plin2) gene-product, PLIN2, commonly called adipose-differentiation related protein (ADRP). These cells are also thought to play a role in alveolarization and repair after injury to the alveolus. Progress in defining the functional contribution of lipofibroblasts to alveolar generation and repair is hampered by a lack of in vivo tools. The present study reports the generation of an inducible mouse Cre-driver line to target cells of the ADRP lineage. Robust Cre-mediated recombination in this mouse line was detected in mesenchymal cells of the postnatal lung, and in additional organs including the heart, liver, and spleen. The generation and validation of this valuable new tool to genetically target, manipulate, and trace cells of the ADRP lineage is critical for assessing the functional contribution of lipofibroblasts to lung development and repair. |
